Thought Leadership

Latest Report

Access valuable insights on payer behaviour

During early-stage development, it has become more critical than ever to factor in payer perspectives and reimbursement dynamics. For a clearer understanding of the payer landscape across US healthcare download the infographic.

Report library


Medtech - Going steady

The medtech sector, like the wider pharma market, has been having a tough time. There are, however, glimmers of light and some interesting developments – including…


Vantage Top 10 Most Read Report

The Evaluate Vantage team has rounded up our Top 10 Most-Read stories. Get up to speed on the big issues that have captured the interest and attention of your peers and…


Asco 2022 eBook

Thousands of abstracts were submitted for the recent Asco meeting in Chicago and 40,000 oncology professionals gathered to delve into cutting-edge research,…


Q1 2022: Choppy Waters eBook

If the first quarter of 2022 was a bellwether for the rest of year, many in the drug development market might want to don wet weather gear and hunker down for a blustery…


Orphan Drug 2022 Report

Treatments for orphan indications and rare diseases are no longer a niche area of focus for developers. Orphan products have become one of the fastest growing areas of…


Genetic Medicine: The Next Generation

Huge investment in the first generation of genetic medicine led, by and large, to incredibly high valuations for companies, and before too long, some in the market began…


Orphan Drug 2022 Infographic

In 2021, over half of the FDA’s new drug approvals were for orphan or rare diseases. While orphan products are one of the fastest-growing areas of drug development, it…


PD(L)anner - March 2022

The Evaluate Vantage PD(L)anner – March 2022 provides news, insights and analysis on the PD-(L)1 antibody landscape. Among other issues, we focus on potential pricing…